Global CDMO NextPharma is a European contract development and manufacturing organization with capabilities across solids, liquids, semi-solids and sterile products, including highly potent compounds and controlled substances, indicating readiness to handle a wide range of customer projects and complex regulatory requirements.

Expansion Footprint The company has grown through acquisitions and facility expansions in multiple European sites (Germany, France, Finland, UK) and is positioned to support cross-border manufacturing and regional supply for global customers.

Therapeutic Scope Capabilities span pharmaceuticals, nutraceuticals, biotech and healthcare products with containment for hormones, narcotics, beta-lactams and highly potent compounds, suggesting opportunities in high-compliance, high-value segments.

Financial Scale With revenue in the several hundreds of millions and a funding base, NextPharma demonstrates financial capacity to take on larger, multi-site development and manufacturing programs for new and existing clients.

Tech & Talent Investments in modern tech stack (SAP SuccessFactors, analytics, ERP, digital ads) and a broad talent pool across Europe indicate strong program management, GMP compliance, and the ability to attract skilled life sciences professionals for complex projects.